Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 26.
doi: 10.1097/CEJ.0000000000000981. Online ahead of print.

Cancer mortality in Europe in 2020, and an overview of trends since 1990

Claudia Santucci  1   2 , Paola Bertuccio  3 , Silvia Mignozzi  1 , Margherita Pizzato  1   4 , Giovanni Corso  5   6 , Anna Odone  3   7 , Eva Negri  4 , Carlo La Vecchia  1 , Gianfranco Alicandro  8   9
Affiliations
Free article

Cancer mortality in Europe in 2020, and an overview of trends since 1990

Claudia Santucci et al. Eur J Cancer Prev. .
Free article

Abstract

Introduction: Cancer remains a leading cause of death in Europe, with over 1.2 million deaths recorded in the EU-27 in 2020.

Methods: Using WHO death certification data for 33 European countries from 1990 to 2020, we analyzed mortality trends for all neoplasms and 24 cancer sites, stratified by sex and age. We computed age-standardized mortality rates (ASMR) and applied joinpoint regression models to evaluate temporal trends.

Results: In 2020, the leading causes of cancer death in the EU-27 were lung (ASMR: 30.1/100 000), colorectal (14.6/100 000), and prostate (9.8/100 000) cancer in males and breast (13.8/100 000), lung (13.2/100 000), and colorectal (8.6/100 000) cancer in females. Pancreatic cancer was the fourth most common cause of cancer death in both sexes (ASMR: 8.2/100 000 males and 5.8/100 000 females). Most Central and Eastern European countries reported rates over two-fold higher compared to Western Europe. While overall cancer mortality declined since 1990 (average annual percent change: -1.3% in males and -0.8% in females in the EU-27), mortality from pancreatic (+0.2% in males and +0.8% in females) and female lung cancer (+1.9%) increased.

Conclusion: Declines in cancer mortality are attributable to reduced tobacco use, and improvements in organized screening programs and treatment. Pancreatic cancer mortality remains stable, while female lung cancer mortality continues to rise in some countries, largely due to later adoption of smoking and low cessation rates. Lower participation in screening programs and limited access to novel therapies in many Central and Eastern European countries contribute to poorer cancer outcomes, highlighting the need for equitable prevention, early detection, and treatment strategies across Europe.

Keywords: Europe; cancer; mortality; trends.

PubMed Disclaimer

References

    1. Ansell SM (2022). Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 97:1478–1488.
    1. Bertuccio P, Alicandro G, Malvezzi M, Carioli G, Boffetta P, Levi F, et al. (2019). Cancer mortality in Europe in 2015 and an overview of trends since 1990. Ann Oncol 30:1356–1369.
    1. Bjorkholm M, Ohm L, Eloranta S, Derolf A, Hultcrantz M, Sjoberg J, et al. (2011). Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol 29:2514–2520.
    1. GBD Alcohol Collaborators (2022). Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet 400:185–235.
    1. GBD Tobacco Collaborators (2021). Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet 397:2337–2360.